Jade Biosciences, Inc.
JBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001798749
No open-market purchases or sales by Jade Biosciences, Inc. insiders were filed in the last 90 days; 153 institutions reported holding it in 13F filings for Q2 2026, worth $1.62B in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Jade Biosciences, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +23 vs. Q2 2021
- Shares held
- 21.7M
- +1.69M (+8.5%) vs. Q2 2021
- Total value
- $452.6M
- −$1.85M (−0.4%) vs. Q2 2021
- New holders
- 29
- 3 more added
- Sold out
- 6
- 4 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 153 | $1.62B |
| Q1 2026 | 120 | $700.3M |
| Q4 2025 | 105 | $726.3M |
| Q3 2025 | 78 | $272.9M |
| Q2 2025 | 75 | $315.1M |
| Q1 2025 | 82 | $79.6M |
| Q4 2024 | 80 | $79.9M |
| Q3 2024 | 75 | $57.8M |
| Q2 2024 | 81 | $45.1M |
| Q1 2024 | 81 | $841.5M |
| Q4 2023 | 64 | $637.8M |
| Q3 2023 | 58 | $386.3M |
| Q2 2023 | 60 | $488.3M |
| Q1 2023 | 66 | $524.1M |
| Q4 2022 | 70 | $802.9M |
| Q3 2022 | 56 | $447.4M |
| Q2 2022 | 51 | $403.0M |
| Q1 2022 | 46 | $475.5M |
| Q4 2021 | 47 | $301.6M |
| Q3 2021 | 41 | $452.6M |
| Q2 2021 | 18 | $454.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Jade Biosciences, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 55 | $1.00K | 0.00% | +55 | New |
| Point72 Hong Kong Ltd | 285 | $6.00K | 0.00% | +285 | New |
| Tower Research Capital LLC (TRC) | 414 | $9.00K | 0.00% | +179+76.2% | Added |
| Ameritas Investment Partners, Inc. | 772 | $16.0K | 0.00% | +772 | New |
| Cubist Systematic Strategies, LLC | 775 | $16.0K | 0.00% | +775 | New |
| Bank of America Corp | 881 | $18.0K | 0.00% | +881 | New |
| Legal & General Group Plc | 941 | $20.0K | 0.00% | +941 | New |
| UBS Group AG | 1,091 | $23.0K | 0.00% | −959−46.8% | Reduced |
| Citigroup Inc | 1,149 | $24.0K | 0.00% | +1,149 | New |
| Royal Bank of Canada | 1,254 | $27.0K | 0.00% | +1,254 | New |
| New York State Common Retirement Fund | 1,800 | $38.0K | 0.00% | +1,800 | New |
| STRS Ohio | 2,300 | $48.0K | 0.00% | +2,300 | New |
| Morgan Stanley | 2,741 | $57.0K | 0.00% | +2,741 | New |
| JPMorgan Chase & Co | 5,242 | $110.0K | 0.00% | +5,242 | New |
| California State Teachers Retirement System | 5,445 | $114.0K | 0.00% | +5,445 | New |
| American International Group, Inc. | 5,515 | $116.0K | 0.00% | +5,515 | New |
| Deutsche Bank AG | 5,794 | $122.0K | 0.00% | +5,794 | New |
| Darwin Global Management, Ltd. | 12,484 | $262.0K | 0.05% | +12,484 | New |
| Old Well Partners, LLC | 12,600 | $264.0K | 0.14% | +12,600 | New |
| Chicago Partners Investment Group LLC | 16,076 | $284.0K | 0.02% | +16,076 | New |
| Nuveen Asset Management, LLC | 14,318 | $300.0K | 0.00% | +14,318 | New |
| Bank of New York Mellon Corp | 21,791 | $457.0K | 0.00% | +21,791 | New |
| Charles Schwab Investment Management Inc | 24,736 | $519.0K | 0.00% | +24,736 | New |
| Parkwood LLC | 48,059 | $1.01M | 0.17% | +48,059 | New |
| Point72 Asset Management, L.P. | 53,872 | $1.13M | 0.01% | +53,872 | New |
| Millennium Management LLC | 69,867 | $1.47M | 0.00% | +4,824+7.4% | Added |
| Northern Trust Corp | 88,205 | $1.85M | 0.00% | +88,205 | New |
| Geode Capital Management, LLC | 114,423 | $2.40M | 0.00% | +114,423 | New |
| State Street Corp | 125,843 | $2.64M | 0.00% | +125,843 | New |
| Parametric Portfolio Associates LLC | 141,638 | $2.97M | 0.00% | +141,638 | New |
| Sectoral Asset Management Inc | 341,367 | $7.16M | 0.60% | −158,633−31.7% | Reduced |
| BlackRock Inc. | 483,018 | $10.1M | 0.00% | +483,018 | New |
| OrbiMed Advisors LLC | 535,714 | $11.2M | 0.12% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 714,285 | $15.0M | 0.29% | 00.0% | Unchanged |
| FMR LLC | 718,351 | $15.1M | 0.00% | −177,466−19.8% | Reduced |
| Vanguard Group Inc | 781,375 | $16.4M | 0.00% | +781,375 | New |
| Citadel Advisors LLC | 1,594,813 | $32.4M | 0.04% | −20,185−1.2% | Reduced |
| Baker Bros. Advisors LP | 1,652,171 | $34.7M | 0.15% | +223,600+15.7% | Added |
| Cormorant Asset Management, LP | 2,030,691 | $42.0M | 1.71% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 3,758,686 | $78.9M | 5.06% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 8,263,982 | $173.4M | 2.40% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −104,755−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −21,070−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −9,854−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −9,000−100.0% | Sold out |
| Kelly Financial Services LLC | 0 | $0 | 0.00% | −91−100.0% | Sold out |